These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 29701909

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.
    Bowring MG, Shaffer AA, Massie AB, Cameron A, Desai N, Sulkowski M, Garonzik-Wang J, Segev DL.
    Am J Transplant; 2019 Aug; 19(8):2329-2341. PubMed ID: 30861279
    [Abstract] [Full Text] [Related]

  • 6. Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation.
    Shelton BA, Sawinski D, Linas BP, Reese PP, Mustian M, Hungerpiller M, Reed RD, MacLennan PA, Locke JE.
    Am J Transplant; 2018 Oct; 18(10):2483-2495. PubMed ID: 30058218
    [Abstract] [Full Text] [Related]

  • 7. Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era.
    Bowring MG, Kucirka LM, Massie AB, Luo X, Cameron A, Sulkowski M, Rakestraw K, Gurakar A, Kuo I, Segev DL, Durand CM.
    Am J Transplant; 2017 Feb; 17(2):519-527. PubMed ID: 27456927
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
    Cotter TG, Paul S, Sandıkçı B, Couri T, Bodzin AS, Little EC, Sundaram V, Charlton M.
    Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
    [Abstract] [Full Text] [Related]

  • 12. Improvements in liver transplant outcomes in patients with HCV/HIV coinfection after the introduction of direct-acting antiviral therapies.
    Shimada S, Ivanics T, Kitajima T, Shamaa T, Rizzari M, Collins K, Yoshida A, Abouljoud M, Moonka D, Zhang J, Lu M, Nagai S.
    Transpl Infect Dis; 2022 Apr; 24(2):e13808. PubMed ID: 35157334
    [Abstract] [Full Text] [Related]

  • 13. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
    Cotter TG, Paul S, Sandıkçı B, Couri T, Bodzin AS, Little EC, Sundaram V, Charlton M.
    Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
    [Abstract] [Full Text] [Related]

  • 14. Effect of Recipient Hepatitis C Status on Outcomes of Deceased Donor Kidney Transplantation.
    Yuan Q, Hong S, Perez-Ortiz A, Roth E, Chang DC, Madsen JC, Elias N.
    J Am Coll Surg; 2020 Jun; 230(6):853-861.e3. PubMed ID: 32035979
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of using kidneys from hepatitis C nucleic acid test-positive donors for transplantation in hepatitis C-negative recipients.
    Kadatz M, Klarenbach S, Gill J, Gill JS.
    Am J Transplant; 2018 Oct; 18(10):2457-2464. PubMed ID: 29797402
    [Abstract] [Full Text] [Related]

  • 16. Changes in practice and perception of hepatitis C and liver transplantation: Results of a national survey.
    Shaffer AA, Thomas AG, Bowring MG, Van Pilsum Rasmussen SE, Cash A, Kucirka LM, Alqahtani SA, Gurakar A, Sulkowski MS, Cameron AM, Segev DL, Durand CM.
    Transpl Infect Dis; 2018 Dec; 20(6):e12982. PubMed ID: 30144258
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy.
    Chan C, Schiano T, Agudelo E, Paul Haydek J, Hoteit M, Laurito MP, Norvell JP, Terrault N, Verna EC, Yang A, Levitsky J.
    Am J Transplant; 2018 Oct; 18(10):2506-2512. PubMed ID: 30075485
    [Abstract] [Full Text] [Related]

  • 20. Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study.
    Dharancy S, Coilly A, Fougerou-Leurent C, Duvoux C, Kamar N, Leroy V, Tran A, Houssel-Debry P, Canva V, Moreno C, Conti F, Dumortier J, Di Martino V, Radenne S, De Ledinghen V, D'Alteroche L, Silvain C, Besch C, Perré P, Botta-Fridlund D, Francoz C, Habersetzer F, Montialoux H, Abergel A, Debette-Gratien M, Rohel A, Rossignol E, Samuel D, Duclos-Vallée JC, Pageaux GP, ANRS CO23 CUPILT study group.
    Am J Transplant; 2017 Nov; 17(11):2869-2878. PubMed ID: 28898563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.